A A Schoemaker1, A B Sprikkelman1, K E Grimshaw2, G Roberts2,3, L Grabenhenrich4, L Rosenfeld5, S Siegert5,6, R Dubakiene7, O Rudzeviciene7, M Reche8, A Fiandor9, N G Papadopoulos10, A Malamitsi-Puchner11, A Fiocchi12, L Dahdah12, S Th Sigurdardottir13, M Clausen14, A Stańczyk-Przyłuska15, K Zeman15,16, E N C Mills17, D McBride4, T Keil4,18, K Beyer5. 1. Department of Pediatric Respiratory Medicine and Allergy, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands. 2. Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. 3. NIHR Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK. 4. Institute of Social Medicine, Epidemiology and Health Economics, Charité University Medical Centre, Berlin, Germany. 5. Department of Paediatric Pneumology and Immunology, Charité University Medical Centre, Berlin, Germany. 6. German Agency for Quality in Medicine, Berlin, Germany. 7. Faculty of Medicine, Vilnius University, Vilnius, Lithuania. 8. Sofia Children's University Hospital, Madrid, Spain. 9. University Hospital La Paz, Madrid, Spain. 10. Department of Allergy, Second Paediatric Clinic, University of Athens, Athens, Greece. 11. Neonatal Division, Second Department of Obstetrics and Gynaecology, University of Athens, Athens, Greece. 12. Division of Allergy, Department of Pediatrics, Pediatric Hospital Bambino Gesù, Rome, Italy. 13. Department of Immunology, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland. 14. Children's Hospital, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland. 15. Department of Pediatrics, Preventive Cardiology and Immunology, Medical University of Łódź, Łódź, Poland. 16. Department of Pediatrics, Immunology and Nephrology, Department of Pediatrics, Clinical Immunology and Cardiology, Polish Mother's Health Centre Research Institute Łódź, Medical University of Łódź, Łódź, Poland. 17. Institute of Inflammation and Repair, Manchester Academic Health Science Centre, Manchester Institute of Biotechnology, University of Manchester, Manchester, UK. 18. Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Abstract
BACKGROUND: Cow's milk allergy (CMA) is one of the most commonly reported childhood food problems. Community-based incidence and prevalence estimates vary widely, due to possible misinterpretations of presumed reactions to milk and differences in study design, particularly diagnostic criteria. METHODS: Children from the EuroPrevall birth cohort in 9 European countries with symptoms possibly related to CMA were invited for clinical evaluation including cows' milk-specific IgE antibodies (IgE), skin prick test (SPT) reactivity and double-blind, placebo-controlled food challenge. RESULTS: Across Europe, 12 049 children were enrolled, and 9336 (77.5%) were followed up to 2 years of age. CMA was suspected in 358 children and confirmed in 55 resulting in an overall incidence of challenge-proven CMA of 0.54% (95% CI 0.41-0.70). National incidences ranged from 1% (in the Netherlands and UK) to <0.3% (in Lithuania, Germany and Greece). Of all children with CMA, 23.6% had no cow's milk-specific IgE in serum, especially those from UK, the Netherlands, Poland and Italy. Of children with CMA who were re-evaluated one year after diagnosis, 69% (22/32) tolerated cow's milk, including all children with non-IgE-associated CMA and 57% of those children with IgE-associated CMA. CONCLUSIONS: This unique pan-European birth cohort study using the gold standard diagnostic procedure for food allergies confirmed challenge-proven CMA in <1% of children up to age 2. Affected infants without detectable specific antibodies to cow's milk were very likely to tolerate cow's milk one year after diagnosis, whereas only half of those with specific antibodies in serum 'outgrew' their disease so soon.
BACKGROUND: Cow's milk allergy (CMA) is one of the most commonly reported childhood food problems. Community-based incidence and prevalence estimates vary widely, due to possible misinterpretations of presumed reactions to milk and differences in study design, particularly diagnostic criteria. METHODS: Children from the EuroPrevall birth cohort in 9 European countries with symptoms possibly related to CMA were invited for clinical evaluation including cows' milk-specific IgE antibodies (IgE), skin prick test (SPT) reactivity and double-blind, placebo-controlled food challenge. RESULTS: Across Europe, 12 049 children were enrolled, and 9336 (77.5%) were followed up to 2 years of age. CMA was suspected in 358 children and confirmed in 55 resulting in an overall incidence of challenge-proven CMA of 0.54% (95% CI 0.41-0.70). National incidences ranged from 1% (in the Netherlands and UK) to <0.3% (in Lithuania, Germany and Greece). Of all children with CMA, 23.6% had no cow's milk-specific IgE in serum, especially those from UK, the Netherlands, Poland and Italy. Of children with CMA who were re-evaluated one year after diagnosis, 69% (22/32) tolerated cow's milk, including all children with non-IgE-associated CMA and 57% of those children with IgE-associated CMA. CONCLUSIONS: This unique pan-European birth cohort study using the gold standard diagnostic procedure for food allergies confirmed challenge-proven CMA in <1% of children up to age 2. Affected infants without detectable specific antibodies to cow's milk were very likely to tolerate cow's milk one year after diagnosis, whereas only half of those with specific antibodies in serum 'outgrew' their disease so soon.
Authors: Edward Mitre; Apryl Susi; Laura E Kropp; David J Schwartz; Gregory H Gorman; Cade M Nylund Journal: JAMA Pediatr Date: 2018-06-04 Impact factor: 16.193
Authors: Ewa Łoś-Rycharska; Marcin Gołębiewski; Marcin Sikora; Tomasz Grzybowski; Marta Gorzkiewicz; Maria Popielarz; Julia Gawryjołek; Aneta Krogulska Journal: Nutrients Date: 2021-05-15 Impact factor: 5.717
Authors: Benjamin Zepeda-Ortega; Anne Goh; Paraskevi Xepapadaki; Aline Sprikkelman; Nicolaos Nicolaou; Rosa Elena Huerta Hernandez; Amir Hamzah Abdul Latiff; Miu Ting Yat; Mohamed Diab; Bakr Al Hussaini; Budi Setiabudiawan; Urszula Kudla; R J Joost van Neerven; Leilani Muhardi; John O Warner Journal: Front Immunol Date: 2021-06-10 Impact factor: 7.561
Authors: Rita Nocerino; Carmen Di Scala; Serena Coppola; Veronica Giglio; Laura Carucci; Linda Cosenza; Luana Voto; Anna Maria Iannicelli; Anna Luzzetti; Roberto Berni Canani Journal: Ital J Pediatr Date: 2021-07-03 Impact factor: 2.638